用于改变经验性抗生素治疗的已用汇总抗生素耐药百分比证据基础是什么?范围综述
该范围综述检索3146篇文献,最终纳入16篇,识别出用于尿路感染、呼吸道感染、脑膜炎、皮肤软组织感染、淋病及骨关节感染的耐药阈值,阈值多基于专家意见估计且范围宽,所依据的六类标准在文献间异质,需标准化。
要点
- 纳入16篇文献报告了用于改变经验性抗生素治疗的耐药阈值。
- 阈值覆盖尿路感染、呼吸道感染、脑膜炎、皮肤软组织感染、淋病和骨关节感染。
- 阈值多基于专家意见估计,依据标准异质且需标准化。
核心结论
- 用于经验性抗生素治疗的耐药阈值数量少,通常基于专家意见估计,因此范围可能较宽。
- 报告阈值所依据的标准异质,需要标准化。
- 鉴于耐药上升趋势,明确需要刚性工具来确定阈值,以最佳且及时的证据支持指南制定。
研究设计与样本
- 范围综述,进行了全面结构化文献检索。
- 使用系统综述软件Rayyan筛选摘要和标题。
- 数据来源为Pubmed以及参考文献列表和灰色文献的手工检索。
- 纳入标准为涉及任何类型细菌感染病并提及或定义用于经验性抗生素治疗决策的耐药阈值的论文。
- 由两名研究者纳入和分析文章,冲突通过讨论或咨询第三名评审者解决。
主要发现
- 共识别3146篇唯一论文,经标题/摘要筛选后全面阅读125篇,最终纳入16篇。
- 纳入论文给出的阈值涉及尿路感染、呼吸道感染、脑膜炎、皮肤软组织感染、淋病和骨关节感染。
- 发现六项常用作阈值依据的标准:疾病严重程度、治疗疗效、药物不良事件、艰难梭菌(Clostridioides difficile)感染风险、费用和耐药增加。
- 各论文用于定义每个阈值的标准数量从一项到六项不等。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Antibiotic resistance requires continuous monitoring by experts to decide whether empirical antibiotic therapies (EATs) should be replaced by alternative antibiotics. The exact moment and criteria for this change are unclear and generally based on consensus between experts. This scoping review aims to identify from the literature the resistance thresholds used for a change in EAT and the criteria on which they are based. METHODS: Scoping review for which a comprehensive structured literature search was conducted. Rayyan, software for systematic reviews, was used for the screening of abstracts and titles. Data sources were Pubmed and a hand-search of reference lists and grey literature. Papers were eligible if they concerned any type of bacterial infectious disease and mentioned or defined antibiotic resistance thresholds for decision-making purposes for EAT. The inclusion and analysis of articles was done by two researchers; any conflicts were resolved through discussion or by consulting a third reviewer. RESULTS: We identified 3146 unique papers. Following title/abstract screening, 125 papers were comprehensively read, and 16 papers were included. The included papers gave thresholds for urinary tract infections, respiratory tract infections, meningitis, skin and soft tissue infections, gonorrhoea, and bone and joint infections. Six criteria were found that were commonly used to base the thresholds on. These were: disease severity, efficacy of treatment, adverse drug events, risk of Clostridioides difficile infection, costs, and increased resistance. The number of criteria used to define each threshold varied from one to six between papers. CONCLUSIONS: The thresholds used for EATs are few, commonly based on expert opinion estimates, and can therefore have broad ranges. Used criteria underlying reported thresholds are heterogenous and require standardization. Considering the rising trend in resistance, there is a clear need for rigid tools to determine thresholds in order to support guideline development with the best and timely evidence.
引用
- Auzin A, Spits M, Tacconelli E, et al. What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review. Clin Microbiol Infect. 2021. PMID: 34906718. doi:10.1016/j.cmi.2021.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。